Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposure

Mark G. Lebwohl^*, Joseph F. Merola, Katelyn Rowland, Megan Miller, Ya Wen Yang, Jenny Yu, Yin You, Daphne Chan, Diamant Thaçi, Richard G. Langley

^*Korrespondierende/r Autor/-in für diese Arbeit